Loss of MYO5B in Mice Recapitulates Microvillus Inclusion Disease and Reveals an Apical Trafficking Pathway Distinct to Neonatal Duodenum

Cellular and Molecular Gastroenterology and Hepatology

Volumn 2, Issue 2, 2016, Pages 131-157

  Weis, Victoria G ^a   Knowles, Byron C ^a   Choi, Eunyoung ^a,b   Goldstein, Anna E ^a   Williams, Janice A ^a   Manning, Elizabeth H ^a,b   Roland, Joseph T ^a   Lapierre, Lynne A ^a,b   Goldenring, James R ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brush Border; Enterocyte Trafficking; MYO5B; NHE3; Rab11a; Rab8a; Syntaxin 3

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EZRIN; IMMUNOGLOBULIN G ANTIBODY; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MESSENGER RNA; MYOSIN V; MYOSIN VB; PROTEIN P120; RAB PROTEIN; RAB11A PROTEIN; RAB8A PROTEIN; SNARE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 3; STX3 PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; UVOMORULIN; VILLIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; CYTOPLASM VESICLE; DIARRHEA; DUODENUM; EMBRYO; ENTEROPATHY; FAILURE TO THRIVE; GENE DELETION; HETEROZYGOSITY; ILEUM; INTERNALIZATION; INTESTINE BRUSH BORDER; INTESTINE CELL; LYSOSOME; MALE; MICROVILLUS INCLUSION DISEASE; MOUSE; NEWBORN; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WATER CONTENT;

EID: 84975763782     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2015.11.009     Document Type: Article

References (37)

1. Erickson R.P., Larson-Thome K., Valenzuela R.K., et al. Navajo microvillous inclusion disease is due to a mutation in MYO5B. Am J Med Genet A 2008, 146A:3117-3119.
2. Muller T., Hess M.W., Schiefermeier N., et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet 2008, 40:1163-1165.
3. Ruemmele F.M., Muller T., Schiefermeier N., et al. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model. Hum Mutat 2010, 31:544-551.
4. Davidson G.P., Cutz E., Hamilton J.R., et al. Familial enteropathy: a syndrome of protracted diarrhea from birth, failure to thrive, and hypoplastic villus atrophy. Gastroenterology 1978, 75:783-790.
5. Ruemmele F.M., Schmitz J., Goulet O. Microvillous inclusion disease (microvillous atrophy). Orphanet J Rare Dis 2006, 1:22.
6. Ameen N.A., Salas P.J. Microvillus inclusion disease: a genetic defect affecting apical membrane protein traffic in intestinal epithelium. Traffic 2000, 1:76-83.
7. Kravtsov D., Mashukova A., Forteza R., et al. Myosin 5b loss of function leads to defects in polarized signalling: implication for microvillus inclusion disease pathogenesis and treatment. Am J Physiol Gastrointest Liver Physiol 2014, 307:G992-G1001.
8. Thoeni C.E., Vogel G.F., Tancevski I., et al. Microvillus inclusion disease: loss of myosin Vb disrupts intracellular traffic and cell polarity. Traffic 2013, 15:22-42.
9. Knowles B.C., Roland J.T., Krishnan M., et al. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. J Clin Invest 2014, 124:2947-2962.
10. Carton-Garcia F., Overeem A.W., Nieto R., et al. Myo5b knockout mice as a model of microvillus inclusion disease. Sci Rep 2015, 5:12312.
11. Schneeberger K., Vogel G.F., Teunissen H., et al. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking. Proc Natl Acad Sci U S A 2015, 112:12408-12413.
12. Lapierre L.A., Avant K.M., Caldwell C.M., et al. Phosphorylation of Rab11-FIP2 regulates polarity in MDCK cells. Mol Biol Cell 2012, 23:2302-2318.
13. Roland J.T., Kenworthy A.K., Peranen J., et al. Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. Mol Biol Cell 2007, 18:2828-2837.
14. Dhekne H.S., Hsiao N.H., Roelofs P., et al. Myosin Vb and Rab11a regulate phosphorylation of ezrin in enterocytes. J Cell Sci 2014, 127:1007-1017.
15. Saotome I., Curto M., McClatchey A.I. Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 2004, 6:855-864.
16. Groisman G.M., Amar M., Livne E. CD10: a valuable tool for the light microscopic diagnosis of microvillous inclusion disease (familial microvillous atrophy). Am J Surg Pathol 2002, 26:902-907.
17. Knowles B.C., Weis V.G., Yu S., et al. Rab11a regulates syntaxin 3 localization and microvillus assembly in enterocytes. J Cell Sci 2015, 128:1617-1626.
18. Sobajima T., Yoshimura S., Iwano T., et al. Rab11a is required for apical protein localisation in the intestine. Biol Open 2014, 4:86-94.
19. Jones E.A., Waldmann T.A. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest 1972, 51:2916-2927.
20. Israel E.J., Taylor S., Wu Z., et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 1997, 92:69-74.
21. Simister N.E., Mostov K.E. An Fc receptor structurally related to MHC class I antigens. Nature 1989, 337:184-187.
22. Bry L., Falk P., Huttner K., et al. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci U S A 1994, 91:10335-10339.
23. Shah U., Dickinson B.L., Blumberg R.S., et al. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res 2003, 53:295-301.
24. Rodewald R. Intestinal transport of antibodies in the newborn rat. J Cell Biol 1973, 58:189-211.
25. He W., Ladinsky M.S., Huey-Tubman K.E., et al. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 2008, 455:542-546.
26. Sato K., Nagai J., Mitsui N., et al. Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells. Life Sci 2009, 85:800-807.
27. Vogel G.F., Klee K.M., Janecke A.R., et al. Cargo-selective apical exocytosis in epithelial cells is conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3. J Cell Biol 2015, 211:587-604.
28. Phillips A.D., Jenkins P., Raafat F., et al. Congenital microvillous atrophy: specific diagnostic features. Arch Dis Child 1985, 60:135-140.
29. James P.S., Smith M.W., Tivey D.R. Single-villus analysis of disaccharidase expression by different regions of the mouse intestine. J Physiol 1988, 401:533-545.
30. Dowling R.H., Booth C.C. Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967, 32:139-149.
31. Tappenden K.A. Mechanisms of enteral nutrient-enhanced intestinal adaptation. Gastroenterology 2006, 130:S93-S99.
32. Sun X., Spencer A.U., Yang H., et al. Impact of caloric intake on parenteral nutrition-associated intestinal morphology and mucosal barrier function. JPEN J Parenter Enteral Nutr 2006, 30:474-479.
33. Sakamoto K., Hirose H., Onizuka A., et al. Quantitative study of changes in intestinal morphology and mucus gel on total parenteral nutrition in rats. J Surg Res 2000, 94:99-106.
34. Buchman A.L., Moukarzel A.A., Bhuta S., et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 1995, 19:453-460.
35. Feng Y., Sun X., Yang H., et al. Dissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy. J Physiol 2009, 587:641-654.
36. Girard M., Lacaille F., Verkarre V., et al. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease. Hepatology 2014, 60:301-310.
37. Wakabayashi Y., Dutt P., Lippincott-Schwartz J., et al. Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells. Proc Natl Acad Sci U S A 2005, 102:15087-15092.